Clinical and pathologic features of nephropathy with C1q deposits


Cite item

Full Text

Abstract

Aim. To determine the frequency, clinical and morphological features of a nephropathy with C1q deposits in chronic glomerulonephritis adult patients. Materials and methods. 296 specimens of kidneys of patients with a chronic glomerulonephritis (CGN) from 2014 for 2018 were analyzed. At the first step, specimens with C1q deposits in glomeruli revealed by immunofluorescent method were chosen. Lupus nephritis and primary membranoproliferative glomerulonephritis were exclusion criteria. At the second step, the retrospective analysis of the clinical characteristics was carried out. Results and discussion. Deposits of C1q in kidneys at 12 of 296 (4.05%) CGN were revealed, m:f ratio 2:1. Average age of the beginning of a disease was 32.1±14.7 years. At a morphological research in 8 membranous nephropathy (MN), in 2 mesangioproliferative glomerulonephritis (MesPGN), in 2 - nephrosclerosis was revealed. Among 12 patients in 5 the disease debuted a nephrotic syndrome, at the others - a proteinuria from 0.5 to 4.0 g/days with the subsequent formation of a nephrotic syndrome. In 5 of 12 patients the disease was characterized by a favor course with preserved kidney function. At 7 patients at the time of inspection decrease in function of kidneys [glomerular filtration rate (eGFR) 31 (30-34) ml/min] was noted. 5 had slow progressing of a renal failure. 2 of 12 progressed to renal failure (eGFR to 19 and 24 ml/min) within a year. Conclusion. Deposits of C1q in kidney were revealed in 4.05% of biopsy specimens in CGN. The most frequent morphological form was the membranous nephropathy. The clinical course was characterized by a nephrotic syndrome, more than at a half of patients - with renal dysfunction.

About the authors

N. V Chebotareva

Sechenov First Moscow State Medical University (Sechenov University)

Email: natasha_tcheb@mail.ru
к.м.н., доц. каф. внутренних, профессиональных болезней и ревматологии медико-профилактического факультета; тел.: +7(905)543-42-50; ORCID: 0000-0003-2128-8560 Moscow, Russia

A. A Vinogradov

Sechenov First Moscow State Medical University (Sechenov University)

студент международной школы «Медицина будущего» Moscow, Russia

A. N Grishina

Sechenov First Moscow State Medical University (Sechenov University)

аспирант каф. патологической анатомии лечебного факультета Moscow, Russia

L. V Kozlovskaya(Lysenko)

Sechenov First Moscow State Medical University (Sechenov University)

д.м.н., проф. каф. внутренних, профессиональных болезней и ревматологии медико-профилактического факультета Moscow, Russia

V. A Varshavsky

Sechenov First Moscow State Medical University (Sechenov University)

д.м.н., проф. каф. патологической анатомии лечебного факультета Moscow, Russia

References

  1. Jennette J.C, Hipp C.G. C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis. 1985;6(2):103-10.
  2. Iskandar S.S, Browning M.C, Lorentz W.B. Clq nephropathy: a pediatric clinicopathologic study. Am J Kidney Dis. 1991;18(4):459-65. doi: https://doi.org/10.1016/S0272-6386(12)80114-4
  3. Markowitz G.S, Schwimmer J.A, Stokes M.B, et al. C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int. 2003;64(4):1232-40. doi: 10.1046/j.1523-1755.2003.00218.x
  4. Gunasekara V.N, Sebire N.J, Tullus K. C1q nephropathy in children: clinical characteristics and outcome. Ped Nephrol. 2014;29(3):407-13. doi: 10.1007/s00467-013-2692-4
  5. Vizjak A, Ferluga D, Rozic M, et al. Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol. 2008;19(11):2237-44. doi: 10.1681/ASN.2007080929
  6. Fukuma Y, Hisano S, Segawa Y, et al. Clinicopathologic correlation of C1q nephropathy in children. Am J Kidney Dis. 2006;47(3):412-8. doi: 10.1053/j.ajkd.2005.11.013
  7. Hisano S, Fukuma Y, Segawa Y, et al. Clinicopathologic correlation and outcome of C1q nephropathy. Clin J Am Soc Nephrol. 2008;3(6):1637-43. doi: 10.2215/CJN.00830208
  8. Srivastava T, Chadha V, Taboada E.M, et al. C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis. Pediatr Nephrol. 2000;14(10-11):976-9. doi: 10.1007/s004670050056
  9. Deurwaarder E.S, Steenbergen E.J, Hoogeveen E.K, et al. Membranous nephropathy with predominance of C1q: another variant of C1q nephropathy? Clin Nephrol. 2012;77(6):501-4. doi: 10.5414/CN106969
  10. Lau K.K, Gaber L.W, Delos Santos N.M, et al. C1q nephropathy: features at presentation and outcome. Pediatr Nephrol. 2005;20(6):744-9. doi: 10.1007/s00467-004-1810-8
  11. Levart T.K, Kenda R.B, Avgustin Cavić M, et al. C1Q nephropathy in children. Pediatr Nephrol. 2005;20(12):1756-61. doi: 10.1007/s00467-005-2040-4
  12. Nishida M, Kawakatsu H, Okumura Y, et al. C1q nephropathy with asymptomatic urine abnormalities. Pediatr Nephrol. 2005;20(11):1669-70. doi: 10.1007/s00467-005-2024-4
  13. Larsen C.P, Messias N.C, Silva F.G, et al. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol. 2013;26(5):709. doi: 10.1038/modpathol.2012.207
  14. Mii A, Shimizu A, Masuda Y, et al. Current status and issues of C1q nephropathy. Clin Exper Nephrol. 2009;13(2):263-74. doi: 10.1007/s10157-009-0159-5
  15. Sharman A, Furness P, Feehally J. Distinguishing C1q nephropathy from lupus nephritis. Nephrol Dial Transplant. 2004;19:1420-6. doi: 10.1093/ndt/gfh139

Copyright (c) 2019 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies